1 – 6 of 6
- show: 100
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Effect of dronedarone vs. placebo on atrial fibrillation progression : a post hoc analysis from ATHENA trial
2023) In Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 25(3). p.845-854(
- Contribution to journal › Article
- 2022
-
Mark
Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction : a post-hoc analysis of the ATHENA trial
(
- Contribution to journal › Article
- 2020
-
Mark
Efficacy and safety of dronedarone by atrial fibrillation history duration : Insights from the ATHENA study
(
- Contribution to journal › Article
-
Mark
Efficacy and safety of dronedarone in patients with a prior ablation for atrial fibrillation/flutter : Insights from the ATHENA study
(
- Contribution to journal › Article
- 2007
-
Mark
Outcome parameters for trials in atrial fibrillation: executive summary
(
- Contribution to journal › Scientific review
-
Mark
Outcome parameters for trials in atrial fibrillation - Recommendations from a consensus conference organized by the German atrial fibrillation competence NETwork and the European Heart Rhythm Association
(
- Contribution to journal › Scientific review